Search database
Filter
1384
Text search: drug approval
Featured
Language
Document type
849
230
167
56
33
26
13
4
3
2
1
Countries / Regions
92
43
42
38
37
35
34
30
28
28
26
25
23
23
22
22
21
19
19
18
16
16
14
13
12
12
11
9
8
8
8
8
8
6
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
186
72
69
52
26
25
20
18
13
12
12
10
10
9
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
615
117
41
35
34
19
12
1
Toolboxes
169
132
101
74
72
64
35
25
25
24
21
17
12
11
11
11
9
6
5
5
4
2
1
 Download
  View PDF
 Add to my MEDBOX

Prevention Gap Report

UNAIDS; AIDSinfo (2016) C2
Joint United Nations Programme on HIV/AIDS
 Download
  View PDF
 Add to my MEDBOX

The impact of transition from global fund support to governmental funding on the sustainability of harm reduction programs

S. Ibisevic; G. Shaw; Dr. S. Godinjak; Dr. Z. Cardaklija; et al. Eurasian Harm Reduction Network; ICASO (2016) C2
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw. EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson ... more
 Download
  View PDF
 Add to my MEDBOX

The impact of transition from Global Fund support to govermental funding on the sustainability of Harm Reduction programs

G. Shaw Eurasian Harm Reduction Network; ICASO (2016) C2
A case study from Albania June 2016 EHRN is grateful to all who contributed to this document, especially (in alphabetical order): Alena Alba, Program Officer, Eastern Europe and Central Asia Team, Asia, Europe, Latin America and the Caribbean Department, The Global Fund to Fight AIDS, Tuberc ... more
 External Link
 Add to my MEDBOX

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia

T. Tsertsvadze; N. Chkhartishvili; L. Sharvadze; et al. Hindawi Publishing Corporation AIDS Research and Treatment (2011) C2
Research Article Hindawi Publishing Corporation AIDS Research and Treatment Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
 Download
  View PDF
 Add to my MEDBOX

Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care

E. Ruadze; N. Chkhartishvili; O. Chokoshvili; T. Tsertsvadze SAGE Open Medicine (2017) C2
Original Article SAGE Open Medicine Volume 5: 1–7 © The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav httpDs:O//dIo: i1.o0r.g1/107.171/2770/52035013212171773311977 journals.sagepub.com/home/smo
 Download
  View PDF
 Add to my MEDBOX

HIV Programme Review in Georgia

J. V. Lazarus; A. Sönnerborg; H. Fuenzalida; E. Subata World Health Organization (Europe); Centre for Health & Infectious Disease Research (2015) C_WHO
March 2015
 Download
  View PDF
 Add to my MEDBOX

Slowing of the HIV Epidemic in Ukraine: Evidence from Case Reporting and Key Population Surveys, 2005–2012

C. R. Vitek; J.-I. Cakalo; Y .V. Kruglov; et al. PLOS One (2014) C2
PLOS ONE | www.plosone.org September 2014 | Volume 9 | Issue 9 | e103657
 Download
  View PDF
 Add to my MEDBOX

JPS 2012-2016

UNAIDS (2019) C2
Zero new HIV infections Zero Discrimination Zero AIDS related deaths Accessed: 04.10.2019
 Download
  View PDF
 Add to my MEDBOX

Burden sharing or burden shifting? - HIV and TB

Médecins Sans Frontières (MSF) (2019) C1
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ... more
 Download
  View PDF
 Add to my MEDBOX

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

E. J. Abrams; J. Ananworanich; M. Archary; M.N. Ngongondo; P. Brouwers J Acquir Immune Defic Syndr; Pub Med (2018) C2
J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
 Download
  View PDF
 Add to my MEDBOX

Stigmatization and Discrimination toward People Living with HIV/AIDS in a Coastal City of South India

N. Kumar; B. Unnikrishnan; R. Thapar Journal of the International Association of Providers of AIDS Care; SAGE Journals (2017) C2
Journal of the International Association of Providers of AIDS Care 2017, Vol. 16(3) 226–232
 Download
  View PDF
 Add to my MEDBOX

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO
Accessed: 19.10.2019
 External Link
 Add to my MEDBOX

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

D. Ford; R. Turner; A. Turkova; et al. JAIDS Journal of Acquired Immune Deficiency Syndromes; Ovid (2018) C2
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
 Download
  View PDF
 Add to my MEDBOX

Factors associated with depression among HIV/AIDS children in China

E. Zhou; Z. Qiao; Y. Cheng; et al. International Journal of Mental Health Systems; BioMed Central (2019) CC
Zhou et al. Int J Ment Health Syst (2019) 13:10 https://doi.org/10.1186/s13033-019-0263-1
 Download
  View PDF
 Add to my MEDBOX

Effective Laws to End HIV and AIDS: Next Steps for Parliaments

V. Oakeshott; L. Davies; T. Khumalo; et al. Inter-Parliamentary Union (For democracy, For everyone); UNDP (Empowered lives, Resilient nations) (2013) C2
 External Link
 Add to my MEDBOX

Survival rate and mortality risk factors among TB–HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study

Z. Z. Aunga; Y. M. Saw; T. N. Saw; et al. International Journal of Infectious Diseases; Elsevier; International Society for infectious diseases (2019) C2
International Journal of Infectious Diseases 80 (2019) 10–15 journal homepage: www.elsevier.com/locate/ijid
 External Link
 Add to my MEDBOX

Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle- Income Countries: A Forecast Analysis 2015- 2025

A. Gupta; S. Juneja; M. Vitoria; et al. PLOS ONE (2016) CC
Research Article PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
 Download
  View PDF
 Add to my MEDBOX

Fit for purpose - Antiretroviral treatment optimisation

P. Clayden Unitaid; HIV i-Base (2018) C2
HIV i-Base July 2018
 Download
  View PDF
 Add to my MEDBOX

Transition to new antiretroviral drugs in HIV programmes: Clinical and programmatic considerations

M. Doherty; M. Vitoria; M. Penazzato; et al. World Health Organization (2017) C_WHO
Technical Update HIV Treatment July 2017
 Download
  View PDF
 Add to my MEDBOX

Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin

Serge Ade, Omer Adjibodé, Prudence Wachinou, Narcisse Toundoh, Bérénice Awanou, Gildas Agodokpessi, Dissou Affolabi, Gabriel Adè, Anthony D. Harries, Séverin Anagonou Hindawi (2016) C2
Patients with retreatment tuberculosis (TB) represent those who have been treated previously for onemonth ormorewith anti-TB drugs and who have been diagnosed once again with the disease.These patientsmainly include relapses, treatment after failure, or loss to follow-up on a first-line treatmen ... more